PURPOSE: This article reviews the role of selective internal irradiation (SIR) with yttrium-90
(90Y) microspheres for hepatocellular carcinoma (HCC). METHODS AND MATERIALS …

Background Selective internal radiation therapy (SIRT) with yttrium-90 resin (Y-90 resin)
microspheres has been used as a locoregional therapy for patients with unresectable …

To present a critical review of yttrium-90 (TheraSphere) for the treatment of hepatocellular
carcinoma (HCC). Medical literature databases (Medline, Cochrane Library, and …

Background This retrospective analysis was undertaken to evaluate the efficiency of SIRT
with Y-90 microspheres and determined prognostic factors affecting patients with …

BACKGROUND & AIMS: Hepatocellular carcinoma (HCC) has limited treatment options;
long-term outcomes following intra-arterial radiation are unknown. We assessed clinical …

Hepatocellular carcinoma is the most common primary liver cancer and it represents the
majority of cancer-related deaths in the world. More than 70% of patients present at an …

Background Hepatocellular carcinoma (HCC) is aggressive primary malignancy of the liver
that most commonly presents late in the disease course. As a result, the majority of patients …

Hepatocellular carcinoma (HCC) constitutes a difficult health challenge because of its poor
prognosis and limited treatment options. Most available therapies are used only for …

Hepatocellular carcinoma (HCC) is a disease usually diagnosed in its advanced-stage, and
is frequently not amenable to curative surgical treatment. Also, HCC is resistant to …

Purpose: To evaluate the efficacy of intraarterial 90yttrium (90Y) microspheres in
nonresectable hepatocellular carcinoma (HCC). Methods and Materials: Patients with …